文献速递关节外科

55岁及以下患者伯明翰髋关节表面置换术:中期不良结局的危险因素

Birmingham Hip Resurfacing in Patients 55 Years or Younger: Risk Factors for Poor Midterm Outcomes.
PubMed 文献 · J Arthroplasty · 2017-01-03

回顾性分析442例55岁及以下接受伯明翰髋关节表面置换术(BHR)的患者,平均随访71.68±10.24个月。单因素分析显示仅女性性别和较小股骨头尺寸与无菌性翻修、全因翻修及全因并发症显著相关,多因素分析显示两者密切相关,女性性别是比头尺寸更好的不良结局预测因素。5年假体生存率女性95.1% vs 男性99.0%。

要点

  • 女性性别和较小股骨头尺寸与BHR术后无菌性翻修、全因翻修及并发症显著相关。
  • 女性性别是比头尺寸更好的不良结局预测因素,小头尺寸可视为女性性别的替代指标。
  • 5年假体生存率女性95.1% vs 男性99.0%。

核心结论

  • BHR在年轻退行性髋关节疾病患者中具有极好的生存率。
  • 本研究提示股骨头模板尺寸较小的女性可能不适合作为BHR候选者,但需要进一步研究以更好地理解性别差异。

研究设计与样本

  • 回顾性综述了442例连续患者,随访5年,进行单因素分析后以多因素分析控制潜在混杂因素。

主要发现

  • 平均随访71.68±10.24个月。
  • 单因素分析中,仅女性性别和较小股骨头尺寸与无菌性翻修、全因翻修及全因并发症有显著关系。
  • 多因素logistic回归模型显示两个变量密切相关,女性性别是比头尺寸更好的不良结局预测因素(即小头尺寸可视为女性性别的替代指标)。
  • 5年假体生存率女性95.1% vs 男性99.0%。

局限性

  • 本研究为回顾性研究。
  • 需要进一步研究以更好地理解性别差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Birmingham hip resurfacing (BHR) is the only Food and Drug Administration-approved hip resurfacing system available in the United States and is used as an alternative to conventional total hip arthroplasty in younger patients. The purpose of this study is to report on the midterm outcomes of BHR in patients 55 years and younger, and specifically to examine the risk factors for aseptic failure, all-cause revision, and complications in this patient population. METHODS: Four hundred forty-two consecutive patients with 5-year follow-up were retrospectively reviewed. Multivariate analyses were conducted to control for potential confounding factors identified by univariate analyses. RESULTS: Mean follow-up was 71.68 ± 10.24 months. Among the potential risk factors, only female gender and smaller head sizes had a significant univariate relationship with aseptic revision, all-cause revision, and all-cause complications. When both risk factors were included in a multivariable logistic regression model, analyses showed both variables were closely related, with female gender a better predictor of adverse outcomes than head size (ie, small head size can be thought of as a proxy for female gender). The 5-year implant survival is 95.1% females compared to 99.0% in males. CONCLUSION: Hip resurfacing with BHR has excellent survival rates in young patients with degenerative hip disease. Although this study suggests that females with small templated head sizes may not be suitable candidates for BHR, further studies are needed to better understand the underlying differences in gender.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Halawi MJ, Brigati D, Messner W, et al. Birmingham Hip Resurfacing in Patients 55 Years or Younger: Risk Factors for Poor Midterm Outcomes. J Arthroplasty. 2017. PMID: 28108170. doi:10.1016/j.arth.2016.12.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。